Literature DB >> 16844891

Do clinicians follow a risk-sensitive model of capacity-determination? An experimental video survey.

Scott Y H Kim1, Eric D Caine, Jeffrey G Swan, Paul S Appelbaum.   

Abstract

The authors asked whether clinicians use a risk-sensitive model for decisional-capacity determinations; that is, whether a higher degree of capacity was required in higher-risk situations. The respondents were randomly assigned to view a videotaped "capacity" interview of a medication-randomized clinical trial scenario (N=52) or a neurosurgical clinical trial scenario (N=47). A significant scenario effect was mediated by the respondents' perception of scenario-specific risk. Respondents showed considerable disagreement within each scenario that was not explained by clinician-specific factors. Thus, clinicians, in fact, use the normative risk-sensitive model for capacity, but there remains considerable unexplained variability in their judgments.

Mesh:

Year:  2006        PMID: 16844891     DOI: 10.1176/appi.psy.47.4.325

Source DB:  PubMed          Journal:  Psychosomatics        ISSN: 0033-3182            Impact factor:   2.386


  17 in total

Review 1.  The ethics of informed consent in Alzheimer disease research.

Authors:  Scott Y H Kim
Journal:  Nat Rev Neurol       Date:  2011-05-24       Impact factor: 42.937

2.  Capacity Evaluations of Psychiatric Patients Requesting Assisted Death in the Netherlands.

Authors:  Samuel N Doernberg; John R Peteet; Scott Y H Kim
Journal:  Psychosomatics       Date:  2016-06-29       Impact factor: 2.386

3.  Variability of judgments of capacity: experience of capacity evaluators in a study of research consent capacity.

Authors:  Scott Y H Kim; Paul S Appelbaum; H Myra Kim; Ian F Wall; James A Bourgeois; Bernard Frankel; Kevin C Hails; James R Rundell; Kathleen M Seibel; Jason H Karlawish
Journal:  Psychosomatics       Date:  2011-03-31       Impact factor: 2.386

4.  Preservation of the capacity to appoint a proxy decision maker: implications for dementia research.

Authors:  Scott Y H Kim; Jason H Karlawish; H Myra Kim; Ian F Wall; Andrea C Bozoki; Paul S Appelbaum
Journal:  Arch Gen Psychiatry       Date:  2011-02

5.  Ethics in Psychiatric Research: A Review of 25 Years of NIH-funded Empirical Research Projects.

Authors:  James Dubois; Holly Bante; Whitney B Hadley
Journal:  AJOB Prim Res       Date:  2011-12-06

6.  Neuropsychological correlates of capacity determinations in Alzheimer disease: implications for assessment.

Authors:  Barton W Palmer; Kerry A Ryan; H Myra Kim; Jason H Karlawish; Paul S Appelbaum; Scott Y H Kim
Journal:  Am J Geriatr Psychiatry       Date:  2013-01-11       Impact factor: 4.105

7.  Cognitive impairment and PD patients' capacity to consent to research.

Authors:  Jason Karlawish; Mark Cary; Stephen T Moelter; Andrew Siderowf; Elizabeth Sullo; Sharon Xie; Daniel Weintraub
Journal:  Neurology       Date:  2013-07-26       Impact factor: 9.910

8.  Multimedia consent for research in people with schizophrenia and normal subjects: a randomized controlled trial.

Authors:  Dilip V Jeste; Barton W Palmer; Shahrokh Golshan; Lisa T Eyler; Laura B Dunn; Thomas Meeks; Danielle Glorioso; Ian Fellows; Helena Kraemer; Paul S Appelbaum
Journal:  Schizophr Bull       Date:  2008-01-31       Impact factor: 9.306

9.  Interpreting the clinical significance of capacity scores for informed consent in Alzheimer disease clinical trials.

Authors:  Jason Karlawish; Scott Y H Kim; David Knopman; Christopher H van Dyck; Bryan D James; Daniel Marson
Journal:  Am J Geriatr Psychiatry       Date:  2008-06-12       Impact factor: 4.105

10.  Capacity, Vulnerability, and Informed Consent for Research.

Authors:  Michelle Biros
Journal:  J Law Med Ethics       Date:  2018-03-27       Impact factor: 1.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.